Higher ANA Titers Linked to Increased Risks of Infertility and Miscarriage – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“ANA in IVF
Recent research by Yoshihara et al. (2025) offers key insights into anti-nuclear antibodies (ANA) in reproductive health. They determined that low-titer ANA (≤1:160) does not significantly impact live birth rates, suggesting a threshold where these antibodies may become clinically relevant. Conversely, higher ANA titers have previously been linked to increased risks of infertility and miscarriage.
This study emphasizes the importance of monitoring ANA levels in pregnancy planning and highlights the need for further research into how these antibodies influence reproductive outcomes. Understanding these thresholds can empower couples during their fertility journeys.
Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients Open Access
H Yoshihara, S Goto, Tamao Kitaori, M Sugiura-Ogasawara
Human Reproduction, Volume 40, Issue 2, February 2025, Pages 236–243.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 1, 2026, 03:13International Expert Recommendations in Emerging Reproductive Science – ESHRE
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE